Andy Blum

Scientist, Biogen

Andy has over 40 years’ experience as an analytical scientist in the chemical and pharmaceutical industries and a BS in Biological Sciences. Over the past 16 years at Biogen, Andy’s work has focused on development and optimization of chromatographic and electrophoretic methods for characterization of proteins and gene therapy-based products.

Tackling Analytical Bottlenecks in Next-Generation Drug Development

There are hundreds of drug candidates to screen for purity, integrity and stability during early drug development, which can become a considerable bottleneck.

Webinar

Tackling Analytical Bottlenecks in Next-Generation Drug Development

There are hundreds of drug candidates to screen for purity, integrity and stability during early drug development, which can become a considerable bottleneck.